vimarsana.com
Home
Live Updates
LinKinVax Welcomes Interim Results of the ANRS VRI06 Phase I Trial Evaluating a Novel HIV Vaccine Candidate : comparemela.com
LinKinVax Welcomes Interim Results of the ANRS VRI06 Phase I Trial Evaluating a Novel HIV Vaccine Candidate
First vaccine to target dendritic cells, key activators of the immune system Novel delivery of the HIV envelope protein potentially critical to future vaccine strategies Safe and able
Related Keywords
France ,
Paris ,
France General ,
Switzerland ,
Dennis Riedl ,
Jacques Auberton Herv ,
Corinne Margot ,
Annie Florence Loyer ,
Vaccine Research Institute ,
Yves Levy ,
Executive Director ,
Scientific Advisory Board ,
Opportunistic Infections ,
Honorary Chairman ,
Florence Loyer ,
Linkinvax ,
Elcomes ,
Interim ,
Results ,
Nrs ,
Ri06 ,
Hase ,
Trial ,
Valuating ,
Novel ,
Vaccine ,
Candidate ,
comparemela.com © 2020. All Rights Reserved.